Correlation between spectral domain optical coherence tomography findings and visual outcomes in central retinal vein occlusion

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 299-305

  Lima, Verônica Castro ^a   Yeung, Ling ^a,b   Castro, Leonardo C ^c   Landa, Gennady ^a   Rosen, Richard B ^a,d  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c TUFTS MEDICAL CENTER   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Inner retinal layers; Macular edema; Macular ischemia

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; EARLY DIAGNOSIS; EYE BLOOD FLOW; FEMALE; HUMAN; LASER COAGULATION; MALE; NEOVASCULAR GLAUCOMA; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTORECEPTOR INNER SEGMENT; PREDICTION; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINA INNER PLEXIFORM LAYER; RETINA ISCHEMIA; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; RETINA ROD OUTER SEGMENT; SUBRETINAL FLUID; VISUAL ACUITY;

EID: 79952837709     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S16253     Document Type: Article

References (28)

1. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997; 115:486-491.
2. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology. 1996;103:551-560.
3. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. M report. Ophthalmology. 1995;102:1425-1433.
4. Binder S, Aggermann T, Brunner S. Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series. Graefes Arch Clin Exp Ophthalmol. 2007;245:1447-1452.
5. Ghazi NG, Noureddine B, Haddad RS, Jurdi FA, Bashshur ZF. Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina. 2003;23:780-784.
6. Goff MJ, Jumper JM, Yang SS, et al. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion. Retina. 2006;26:896-901.
7. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 2006;26:279-284.
8. Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol. 2007;143:601-606.
9. Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007;114:507-519.
10. Ota M, Tsujikawa A, Kita M, et al. Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina. 2008;28:1502-1508.
11. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
12. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325-332.
13. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102:217-229.
14. Drexler W. Ultrahigh-resolution optical coherence tomography. J Biomed Opt. 2004;9:47-74.
15. Nassif N, Cense B, Park BH, et al. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett. 2004;29:480-482.
16. Podoleanu AG, Rosen RB. Combinations of techniques in imaging the retina with high resolution. Prog Retin Eye Res. 2008;27:464-499.
17. Srinivasan VJ, Wojtkowski M, Witkin AJ, et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113:2054-2065.
18. Sakamoto A, Hangai M, Yoshimura N. Spectral-domain optical coherence tomography with multiple B-scan averaging for enhanced imaging of retinal diseases. Ophthalmology. 2008;115:1071-1078.
19. Murakami T, Tsujikawa A, Ohta M, et al. Photoreceptor status after resolved macular edema in branch retinal vein occlusion treated with tissue plasminogen activator. Am J Ophthalmol. 2007;143:171-173.
20. Ota M, Tsujikawa A, Murakami T, et al. Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion. Br J Ophthalmol. 2007;91:1644-1649.
21. Ota M, Tsujikawa A, Murakami T, et al. Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2008;145:273-280.
22. Chung EJ, Roh MI, Kwon OW, Koh HJ. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Retina. 2008;28:957-963.
23. Scott IU, VanVeldhuisen PC, Oden NL, et al. SCORE Study Investigator Group. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal veinocclusion. Ophthalmology. 2009;116:504-512.
24. Tso MO. Pathology of cystoid macular edema. Ophthalmology. 1982;89:902-915.
25. Bowers DK, Finkelstein D, Wolff SM, Green WR. Branch retinal vein occlusion. A clinicopathologic case report. Retina. 1987;7:252-259.
26. Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol. 1982;100:1132-1140.
27. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal veinocclusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina. 1981;1:27-55.
28. The Central Vein Occlusion Study Group. Baseline and early natural history report: the Central Vein Occlusion Study. Arch Ophthalmol. 1993;111:1087-1095.